Vanguard-Group

Filing Details

13F-HR • 2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-09
Total Holdings
16,744
Total Value
5531119721493
Accession Number
0001752724-25-099331
Form Type
13F-HR
Manager Name
Vanguard-Group
Data Enrichment
97% identified
16,290 identified454 unidentified

Holdings

16,744 positions • $5.5T total value
Manager:
Search and click to pin securities to the top
Page 199 of 214
Aprea Therapeutics, Inc.
Shares:173.8K
Value:$354.6K
% of Portfolio:0.0% ($354.6K/$5.5T)
HYDROFARM HOLDINGS GROUP, INC.
Shares:187.6K
Value:$354.6K
% of Portfolio:0.0% ($354.6K/$5.5T)
5E Advanced Materials, Inc.
Shares:92.3K
Value:$353.5K
% of Portfolio:0.0% ($353.5K/$5.5T)
TherapeuticsMD, Inc.
Shares:381.9K
Value:$353.3K
% of Portfolio:0.0% ($353.3K/$5.5T)
NEPHROS INC
Shares:204.2K
Value:$351.2K
% of Portfolio:0.0% ($351.2K/$5.5T)
North American Construction Group Ltd.
Shares:22.3K
Value:$350.9K
% of Portfolio:0.0% ($350.9K/$5.5T)
ASTROTECH Corp
Shares:53.7K
Value:$347.7K
% of Portfolio:0.0% ($347.7K/$5.5T)
Beyond Air, Inc.
Shares:1.3M
Value:$345.2K
% of Portfolio:0.0% ($345.2K/$5.5T)
PALATIN TECHNOLOGIES INC
Shares:591.9K
Value:$345.1K
% of Portfolio:0.0% ($345.1K/$5.5T)
46435G516
Shares:4.2K
Value:$341.5K
% of Portfolio:0.0% ($341.5K/$5.5T)
Marker Therapeutics, Inc.
Shares:275.3K
Value:$338.7K
% of Portfolio:0.0% ($338.7K/$5.5T)
Accelerate Diagnostics, Inc
Shares:478.1K
Value:$335.1K
% of Portfolio:0.0% ($335.1K/$5.5T)
SolarMax Technology, Inc.
Shares:277.4K
Value:$332.9K
% of Portfolio:0.0% ($332.9K/$5.5T)
DONEGAL GROUP INC
Shares:20.3K
Value:$331.6K
% of Portfolio:0.0% ($331.6K/$5.5T)
Anteris Technologies Global Corp.
Shares:91.1K
Value:$331.6K
% of Portfolio:0.0% ($331.6K/$5.5T)
SPDR DOW JONES INDUSTRIAL AVERAGE ETF TRUST
Shares:788
Value:$330.7K
% of Portfolio:0.0% ($330.7K/$5.5T)
78464A409
Shares:4.1K
Value:$330.2K
% of Portfolio:0.0% ($330.2K/$5.5T)
Equillium, Inc.
Shares:841.9K
Value:$330.0K
% of Portfolio:0.0% ($330.0K/$5.5T)
042255109
Shares:328.3K
Value:$328.3K
% of Portfolio:0.0% ($328.3K/$5.5T)
RELMADA THERAPEUTICS, INC.
Shares:1.2M
Value:$326.2K
% of Portfolio:0.0% ($326.2K/$5.5T)